KRAS

Sandra Stickler1, Barbara Rath1, Gerhard Hamilton1

  • 1Institute of Pharmacology, Medical University of Vienna, Vienna, A-1090, Austria.

Oncology research
|April 30, 2024
PubMed
概括

新的KRAS抑制剂针对常见的胰腺癌突变. 像MRTX1133和GEF抑制剂这样的新兴疗法为通过解决流行KRAS突变来治疗胰腺管腺癌 (PDAC) 提供了希望.